CB
DGX icon

CNB Bank’s Quest Diagnostics DGX Stock Holding History

CNB Bank’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Sell
1,513
-102
-6% -$20K 0.13% 126
2026
Q1 		$317K Sell
1,615
-57
-3% -$11.1K 0.13% 124
2025
Q4 		$290K Sell
1,672
-292
-15% -$53.2K 0.12% 127
2025
Q3 		$374K Sell
1,964
-366
-16% -$65K 0.16% 115
2025
Q2 		$419K Sell
2,330
-413
-15% -$71.7K 0.2% 103
2025
Q1 		$464K Sell
2,743
-1,074
-28% -$176K 0.23% 98
2024
Q4 		$576K Sell
3,817
-471
-11% -$73.3K 0.27% 91
2024
Q3 		$666K Sell
4,288
-650
-13% -$97.1K 0.31% 87
2024
Q2 		$676K Sell
4,938
-5,087
-51% -$697K 0.33% 81
2024
Q1 		$1.33M Buy
10,025
+1,576
+19% +$204K 0.65% 44
2023
Q4 		$1.16M Sell
8,449
-393
-4% -$51.7K 0.63% 51
2023
Q3 		$1.08M Sell
8,842
-333
-4% -$44.4K 0.63% 48
2023
Q2 		$1.29M Sell
9,175
-901
-9% -$124K 0.76% 40
2023
Q1 		$1.43M Buy
10,076
+313
+3% +$44.8K 0.87% 35
2022
Q4 		$1.53M Sell
9,763
-75
-0.8% -$10.8K 0.95% 29
2022
Q3 		$1.21M Buy
9,838
+297
+3% +$39.1K 0.82% 34
2022
Q2 		$1.27M Buy
9,541
+448
+5% +$61K 0.82% 34
2022
Q1 		$1.24M Buy
9,093
+262
+3% +$36.5K 0.7% 47
2021
Q4 		$1.53M Sell
8,831
-66
-0.7% -$10K 0.84% 32
2021
Q3 		$1.29M Buy
8,897
+732
+9% +$107K 0.78% 36
2021
Q2 		$1.08M Buy
8,165
+428
+6% +$56K 0.67% 43
2021
Q1 		$993K Buy
7,737
+475
+7% +$58.5K 0.69% 45
2020
Q4 		$865K Buy
7,262
+1,585
+28% +$193K 0.65% 49
2020
Q3 		$650K Buy
5,677
+466
+9% +$55.1K 0.55% 56
2020
Q2 		$594K Buy
+5,211
New +$553K 0.52% 59
2018
Q1 		– Sell
-15
Closed -$1K – 308
2017
Q4 		$1K Buy
+15
New +$1.42K ﹤0.01% 361

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

CNB Bank's DGX Position: Q2 2026 in Review

CNB Bank reduced its Quest Diagnostics (DGX) stake by 6.3% in Q2 2026, selling an estimated $20K and leaving 1,513 shares worth $321K. The position accounts for 0.13% of the portfolio, ranked #126.

CNB Bank first reported a position in DGX in Q4 2017 and has held it in 26 quarters since. The position peaked at $1.53M in Q4 2021. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • CNB Bank held 1,513 shares of Quest Diagnostics worth $321K as of Q2 2026.
  • CNB Bank sold 102 Quest Diagnostics shares in Q2 2026, an estimated $20K.
  • Quest Diagnostics made up 0.13% of CNB Bank's portfolio in Q2 2026, its #126 holding.
  • CNB Bank first reported a position in Quest Diagnostics in Q4 2017 and has held it in 26 quarters since.
  • CNB Bank's Quest Diagnostics position peaked at $1.53M in Q4 2021.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on CNB Bank's 13F filing for Q2 2026, filed 6 Aug 2026.